-
1
-
-
80051580618
-
Cancer statistics, 2011
-
Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011. CA Cancer J Clin 2011, 61:212-236.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 212-236
-
-
Siegel, R.1
Ward, E.2
Brawley, O.3
Jemal, A.4
-
2
-
-
71049115590
-
Sex Differences in Susceptibility to Carcinogens
-
Ramchandran K, Patel JD. Sex Differences in Susceptibility to Carcinogens. Semin Oncol 2009, 36:516-523.
-
(2009)
Semin Oncol
, vol.36
, pp. 516-523
-
-
Ramchandran, K.1
Patel, J.D.2
-
3
-
-
79952276831
-
Sex differences in lung cancer susceptibility: a review
-
Kiyohara C, Ohno Y. Sex differences in lung cancer susceptibility: a review. Gender Medicine 2010, 7:381-401.
-
(2010)
Gender Medicine
, vol.7
, pp. 381-401
-
-
Kiyohara, C.1
Ohno, Y.2
-
4
-
-
79952444583
-
Lung cancer mortality risk among breast cancer patients treated with anti-estrogens
-
Bouchardy C, Benhamou S, Schaffar R, Verkooijen HM, Fioretta G, Schubert H, Vinh-Hung V, Soria J-C, Vlastos G, Rapiti E. Lung cancer mortality risk among breast cancer patients treated with anti-estrogens. Cancer 2011, 117:1288-1295.
-
(2011)
Cancer
, vol.117
, pp. 1288-1295
-
-
Bouchardy, C.1
Benhamou, S.2
Schaffar, R.3
Verkooijen, H.M.4
Fioretta, G.5
Schubert, H.6
Vinh-Hung, V.7
Soria, J.-C.8
Vlastos, G.9
Rapiti, E.10
-
5
-
-
33646119175
-
Non-small-cell lung cancer and breast carcinoma: chemotherapy and beyond
-
Dubey S, Siegfried JM, Traynor AM. Non-small-cell lung cancer and breast carcinoma: chemotherapy and beyond. Lancet Oncol 2006, 7:416-424.
-
(2006)
Lancet Oncol
, vol.7
, pp. 416-424
-
-
Dubey, S.1
Siegfried, J.M.2
Traynor, A.M.3
-
6
-
-
18144381249
-
Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells
-
Pietras RJ, Marquez DC, Chen HW, Tsai E, Weinberg O, Fishbein M. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Steroids 2005, 70:372-381.
-
(2005)
Steroids
, vol.70
, pp. 372-381
-
-
Pietras, R.J.1
Marquez, D.C.2
Chen, H.W.3
Tsai, E.4
Weinberg, O.5
Fishbein, M.6
-
7
-
-
0037204728
-
Ovarian steroid receptors and their role in ovarian function
-
Drummond AE, Britt KL, Dyson M, Jones ME, Kerr JB, O'Donnell L, Simpson ER, Findlay JK. Ovarian steroid receptors and their role in ovarian function. Mol Cell Endocrinol 2002, 191:27-33.
-
(2002)
Mol Cell Endocrinol
, vol.191
, pp. 27-33
-
-
Drummond, A.E.1
Britt, K.L.2
Dyson, M.3
Jones, M.E.4
Kerr, J.B.5
O'Donnell, L.6
Simpson, E.R.7
Findlay, J.K.8
-
8
-
-
0034983121
-
Estrogen and spermatogenesis
-
O'Donnell L, Robertson KM, Jones ME, Simpson ER. Estrogen and spermatogenesis. Endocr Rev 2001, 22:289-318.
-
(2001)
Endocr Rev
, vol.22
, pp. 289-318
-
-
O'Donnell, L.1
Robertson, K.M.2
Jones, M.E.3
Simpson, E.R.4
-
9
-
-
0036376094
-
Estrogen actions throughout the brain
-
McEwen B. Estrogen actions throughout the brain. Recent Prog Horm Res 2002, 57:357-384.
-
(2002)
Recent Prog Horm Res
, vol.57
, pp. 357-384
-
-
McEwen, B.1
-
10
-
-
30944469849
-
Estrogen carcinogenesis in breast cancer
-
Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006, 354:270-282.
-
(2006)
N Engl J Med
, vol.354
, pp. 270-282
-
-
Yager, J.D.1
Davidson, N.E.2
-
11
-
-
33748331145
-
Identification of estrogen receptor alpha variants in breast tumors: implications for predicting response to hormonal therapies
-
Townson SM, O'Connell P. Identification of estrogen receptor alpha variants in breast tumors: implications for predicting response to hormonal therapies. J Surg Oncol 2006, 94:271-273.
-
(2006)
J Surg Oncol
, vol.94
, pp. 271-273
-
-
Townson, S.M.1
O'Connell, P.2
-
12
-
-
0033655310
-
Estrogens as endogenous genotoxic agents-DNA adducts and mutations
-
Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D. Estrogens as endogenous genotoxic agents-DNA adducts and mutations. J Natl Cancer Inst Monogr 2000, 2000:75-93.
-
(2000)
J Natl Cancer Inst Monogr
, vol.2000
, pp. 75-93
-
-
Cavalieri, E.1
Frenkel, K.2
Liehr, J.G.3
Rogan, E.4
Roy, D.5
-
13
-
-
0034783960
-
Mechanisms of estrogen action
-
Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA. Mechanisms of estrogen action. Physiol Rev 2001, 81:1535-1565.
-
(2001)
Physiol Rev
, vol.81
, pp. 1535-1565
-
-
Nilsson, S.1
Makela, S.2
Treuter, E.3
Tujague, M.4
Thomsen, J.5
Andersson, G.6
Enmark, E.7
Pettersson, K.8
Warner, M.9
Gustafsson, J.A.10
-
14
-
-
77953740831
-
Genome-Wide Mapping of Estrogen Receptor-β-Binding Regions Reveals Extensive Cross-Talk with Transcription Factor Activator Protein-1
-
Zhao C, Gao H, Liu Y, Papoutsi Z, Jaffrey S, Gustafsson J-T, Dahlman-Wright K. Genome-Wide Mapping of Estrogen Receptor-β-Binding Regions Reveals Extensive Cross-Talk with Transcription Factor Activator Protein-1. Cancer Res 2010, 70:5174-5183.
-
(2010)
Cancer Res
, vol.70
, pp. 5174-5183
-
-
Zhao, C.1
Gao, H.2
Liu, Y.3
Papoutsi, Z.4
Jaffrey, S.5
Gustafsson, J.-T.6
Dahlman-Wright, K.7
-
15
-
-
79851471023
-
Endocrine therapy of breast cancer
-
Lumachi F, Luisetto G, Basso SM, Basso U, Brunello A, Camozzi V. Endocrine therapy of breast cancer. Curr Med Chem 2011, 18:513-522.
-
(2011)
Curr Med Chem
, vol.18
, pp. 513-522
-
-
Lumachi, F.1
Luisetto, G.2
Basso, S.M.3
Basso, U.4
Brunello, A.5
Camozzi, V.6
-
16
-
-
0031039888
-
Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta
-
Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138:863-870.
-
(1997)
Endocrinology
, vol.138
, pp. 863-870
-
-
Kuiper, G.G.1
Carlsson, B.2
Grandien, K.3
Enmark, E.4
Haggblad, J.5
Nilsson, S.6
Gustafsson, J.A.7
-
17
-
-
0036021712
-
Expression of estrogen receptors alpha and beta in human lung tissue and cell lines
-
Mollerup S, Jorgensen K, Berge G, Haugen A. Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. Lung Cancer 2002, 37:153-159.
-
(2002)
Lung Cancer
, vol.37
, pp. 153-159
-
-
Mollerup, S.1
Jorgensen, K.2
Berge, G.3
Haugen, A.4
-
18
-
-
0036532167
-
Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen
-
Stabile LP, Davis AL, Gubish CT, Hopkins TM, Luketich JD, Christie N, Finkelstein S, Siegfried JM. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res 2002, 62:2141-2150.
-
(2002)
Cancer Res
, vol.62
, pp. 2141-2150
-
-
Stabile, L.P.1
Davis, A.L.2
Gubish, C.T.3
Hopkins, T.M.4
Luketich, J.D.5
Christie, N.6
Finkelstein, S.7
Siegfried, J.M.8
-
19
-
-
13944265574
-
Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects
-
Stabile LP, Lyker JS, Gubish CT, Zhang W, Grandis JR, Siegfried JM. Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects. Cancer Res 2005, 65:1459-1470.
-
(2005)
Cancer Res
, vol.65
, pp. 1459-1470
-
-
Stabile, L.P.1
Lyker, J.S.2
Gubish, C.T.3
Zhang, W.4
Grandis, J.R.5
Siegfried, J.M.6
-
20
-
-
33645985797
-
Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells
-
Dougherty SM, Mazhawidza W, Bohn AR, Robinson KA, Mattingly KA, Blankenship KA, Huff MO, McGregor WG, Klinge CM. Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells. Endocr Relat Cancer 2006, 13:113-134.
-
(2006)
Endocr Relat Cancer
, vol.13
, pp. 113-134
-
-
Dougherty, S.M.1
Mazhawidza, W.2
Bohn, A.R.3
Robinson, K.A.4
Mattingly, K.A.5
Blankenship, K.A.6
Huff, M.O.7
McGregor, W.G.8
Klinge, C.M.9
-
21
-
-
77249155665
-
Sex Differences in Estrogen Receptor Subcellular Location and Activity in Lung Adenocarcinoma Cells
-
Ivanova MM, Mazhawidza W, Dougherty SM, Klinge CM. Sex Differences in Estrogen Receptor Subcellular Location and Activity in Lung Adenocarcinoma Cells. Am J Respir Cell Mol Biol 2010, 42:320-330.
-
(2010)
Am J Respir Cell Mol Biol
, vol.42
, pp. 320-330
-
-
Ivanova, M.M.1
Mazhawidza, W.2
Dougherty, S.M.3
Klinge, C.M.4
-
22
-
-
67349246260
-
Activity and intracellular location of estrogen receptors [alpha] and [beta] in human bronchial epithelial cells
-
Ivanova MM, Mazhawidza W, Dougherty SM, Minna JD, Klinge CM. Activity and intracellular location of estrogen receptors [alpha] and [beta] in human bronchial epithelial cells. Mol Cell Endocrinol 2009, 205:12-21.
-
(2009)
Mol Cell Endocrinol
, vol.205
, pp. 12-21
-
-
Ivanova, M.M.1
Mazhawidza, W.2
Dougherty, S.M.3
Minna, J.D.4
Klinge, C.M.5
-
23
-
-
79551682463
-
Nongenomic Signaling Pathways of Estrogen Toxicity
-
Watson CS, Jeng Y-J, Kochukov MY. Nongenomic Signaling Pathways of Estrogen Toxicity. Toxicol Sci 2010, 115:1-11.
-
(2010)
Toxicol Sci
, vol.115
, pp. 1-11
-
-
Watson, C.S.1
Jeng, Y.-J.2
Kochukov, M.Y.3
-
24
-
-
65649083421
-
Membrane estrogen receptor-alpha-mediated nongenomic actions of phytoestrogens in GH3/B6/F10 pituitary tumor cells
-
Jeng Y-J, Kochukov M, Watson C. Membrane estrogen receptor-alpha-mediated nongenomic actions of phytoestrogens in GH3/B6/F10 pituitary tumor cells. J Mol Signal 2009, 4:2.
-
(2009)
J Mol Signal
, vol.4
, pp. 2
-
-
Jeng, Y.-J.1
Kochukov, M.2
Watson, C.3
-
25
-
-
0035920110
-
Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Galpha(i)
-
Wyckoff MH, Chambliss KL, Mineo C, Yuhanna IS, Mendelsohn ME, Mumby SM, Shaul PW. Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Galpha(i). J Biol Chem 2001, 276:27071-27076.
-
(2001)
J Biol Chem
, vol.276
, pp. 27071-27076
-
-
Wyckoff, M.H.1
Chambliss, K.L.2
Mineo, C.3
Yuhanna, I.S.4
Mendelsohn, M.E.5
Mumby, S.M.6
Shaul, P.W.7
-
26
-
-
0035347192
-
Rapid actions of plasma membrane estrogen receptors
-
Kelly MJ, Levin ER. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 2001, 12:152-156.
-
(2001)
Trends Endocrinol Metab
, vol.12
, pp. 152-156
-
-
Kelly, M.J.1
Levin, E.R.2
-
27
-
-
79952179448
-
Minireview: Extranuclear Steroid Receptors: Roles in Modulation of Cell Functions
-
Levin ER. Minireview: Extranuclear Steroid Receptors: Roles in Modulation of Cell Functions. Mol Endocrinol 2011, 25:377-384.
-
(2011)
Mol Endocrinol
, vol.25
, pp. 377-384
-
-
Levin, E.R.1
-
28
-
-
0037462733
-
Proximal events in signaling by plasma membrane estrogen receptors
-
Razandi M, Pedram A, Park ST, Levin ER. Proximal events in signaling by plasma membrane estrogen receptors. J Biol Chem 2003, 278:2701-2712.
-
(2003)
J Biol Chem
, vol.278
, pp. 2701-2712
-
-
Razandi, M.1
Pedram, A.2
Park, S.T.3
Levin, E.R.4
-
29
-
-
58849143026
-
Estrogen Receptor Beta Functions through Non-genomic Mechanisms in Lung Cancer Cells
-
Zhang G, Liu X, Farkas AM, Parwani AV, Lathrop KL, Lenzner D, Land SR, Srinivas H. Estrogen Receptor Beta Functions through Non-genomic Mechanisms in Lung Cancer Cells. Mol Endocrinol 2009, 23:137-145.
-
(2009)
Mol Endocrinol
, vol.23
, pp. 137-145
-
-
Zhang, G.1
Liu, X.2
Farkas, A.M.3
Parwani, A.V.4
Lathrop, K.L.5
Lenzner, D.6
Land, S.R.7
Srinivas, H.8
-
30
-
-
34547116879
-
Nongenomic beta estrogen receptors enhance beta1 adrenergic signaling induced by the nicotine-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human small airway epithelial cells
-
Majidi M, Al-Wadei HA, Takahashi T, Schuller HM. Nongenomic beta estrogen receptors enhance beta1 adrenergic signaling induced by the nicotine-derived carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human small airway epithelial cells. Cancer Res 2007, 67:6863-6871.
-
(2007)
Cancer Res
, vol.67
, pp. 6863-6871
-
-
Majidi, M.1
Al-Wadei, H.A.2
Takahashi, T.3
Schuller, H.M.4
-
31
-
-
0034802322
-
Cell localization, physiology, and nongenomic actions of estrogen receptors
-
Levin ER. Cell localization, physiology, and nongenomic actions of estrogen receptors. J Appl Physiol 2001, 91:1860-1867.
-
(2001)
J Appl Physiol
, vol.91
, pp. 1860-1867
-
-
Levin, E.R.1
-
32
-
-
0029909596
-
17 beta-estradiol stimulates a rapid Ca2+ influx in LNCaP human prostate cancer cells
-
Audy MC, Vacher P, Duly B. 17 beta-estradiol stimulates a rapid Ca2+ influx in LNCaP human prostate cancer cells. Eur J Endocrinol 1996, 135:367-373.
-
(1996)
Eur J Endocrinol
, vol.135
, pp. 367-373
-
-
Audy, M.C.1
Vacher, P.2
Duly, B.3
-
33
-
-
0026788056
-
A new, nongenomic estrogen action: the rapid release of intracellular calcium
-
Morley P, Whitfield JF, Vanderhyden BC, Tsang BK, Schwartz JL. A new, nongenomic estrogen action: the rapid release of intracellular calcium. Endocrinology 1992, 131:1305-1312.
-
(1992)
Endocrinology
, vol.131
, pp. 1305-1312
-
-
Morley, P.1
Whitfield, J.F.2
Vanderhyden, B.C.3
Tsang, B.K.4
Schwartz, J.L.5
-
34
-
-
0027964862
-
Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription
-
Aronica SM, Kraus WL, Katzenellenbogen BS. Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci U S A 1994, 91:8517-8521.
-
(1994)
Proc Natl Acad Sci U S A
, vol.91
, pp. 8517-8521
-
-
Aronica, S.M.1
Kraus, W.L.2
Katzenellenbogen, B.S.3
-
35
-
-
0030978912
-
Phospholipase C beta and membrane action of calcitriol and estradiol
-
Le Mellay V, Grosse B, Lieberherr M. Phospholipase C beta and membrane action of calcitriol and estradiol. J Biol Chem 1997, 272:11902-11907.
-
(1997)
J Biol Chem
, vol.272
, pp. 11902-11907
-
-
Le Mellay, V.1
Grosse, B.2
Lieberherr, M.3
-
36
-
-
33745361249
-
Membrane initiated estrogen signaling in breast cancer
-
Song RX, Santen RJ. Membrane initiated estrogen signaling in breast cancer. Biol Reprod 2006, 75:9-16.
-
(2006)
Biol Reprod
, vol.75
, pp. 9-16
-
-
Song, R.X.1
Santen, R.J.2
-
37
-
-
33646378684
-
Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin
-
Manavathi B, Kumar R. Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin. J Cell Physiol 2006, 207:594-604.
-
(2006)
J Cell Physiol
, vol.207
, pp. 594-604
-
-
Manavathi, B.1
Kumar, R.2
-
38
-
-
0036127836
-
Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer
-
Filardo EJ. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer. J Steroid Biochem Mol Biol 2002, 80:231-238.
-
(2002)
J Steroid Biochem Mol Biol
, vol.80
, pp. 231-238
-
-
Filardo, E.J.1
-
39
-
-
0033780783
-
Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF
-
Filardo EJ, Quinn JA, Bland KI, Frackelton AR. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 2000, 14:1649-1660.
-
(2000)
Mol Endocrinol
, vol.14
, pp. 1649-1660
-
-
Filardo, E.J.1
Quinn, J.A.2
Bland, K.I.3
Frackelton, A.R.4
-
40
-
-
33751272253
-
Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression
-
Filardo EJ, Graeber CT, Quinn JA, Resnick MB, Giri D, DeLellis RA, Steinhoff MM, Sabo E. Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin Cancer Res 2006, 12:6359-6366.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 6359-6366
-
-
Filardo, E.J.1
Graeber, C.T.2
Quinn, J.A.3
Resnick, M.B.4
Giri, D.5
DeLellis, R.A.6
Steinhoff, M.M.7
Sabo, E.8
-
41
-
-
43549095238
-
Estrogen signaling through the transmembrane G protein-coupled receptor GPR30
-
Prossnitz ER, Arterburn JB, Smith HO, Oprea TI, Sklar LA, Hathaway HJ. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol 2008, 70:165-190.
-
(2008)
Annu Rev Physiol
, vol.70
, pp. 165-190
-
-
Prossnitz, E.R.1
Arterburn, J.B.2
Smith, H.O.3
Oprea, T.I.4
Sklar, L.A.5
Hathaway, H.J.6
-
42
-
-
67349105361
-
Mechanisms of estrogen signaling and gene expression via GPR30
-
Prossnitz ER, Maggiolini M. Mechanisms of estrogen signaling and gene expression via GPR30. Mol Cell Endocrinol 2009, 308:32-38.
-
(2009)
Mol Cell Endocrinol
, vol.308
, pp. 32-38
-
-
Prossnitz, E.R.1
Maggiolini, M.2
-
43
-
-
63849261057
-
G Protein-Coupled Receptor 30: Estrogen Receptor or Collaborator?
-
Levin ER. G Protein-Coupled Receptor 30: Estrogen Receptor or Collaborator?. Endocrinology 2009, 150:1563-1565.
-
(2009)
Endocrinology
, vol.150
, pp. 1563-1565
-
-
Levin, E.R.1
-
44
-
-
76249115409
-
The G Protein-Coupled Receptor GPR30 Inhibits Proliferation of Estrogen Receptor-Positive Breast Cancer Cells
-
Ariazi EA, Brailoiu E, Yerrum S, Shupp HA, Slifker MJ, Cunliffe HE, Black MA, Donato AL, Arterburn JB, Oprea TI, et al. The G Protein-Coupled Receptor GPR30 Inhibits Proliferation of Estrogen Receptor-Positive Breast Cancer Cells. Cancer Res 2010, 70:1184-1194.
-
(2010)
Cancer Res
, vol.70
, pp. 1184-1194
-
-
Ariazi, E.A.1
Brailoiu, E.2
Yerrum, S.3
Shupp, H.A.4
Slifker, M.J.5
Cunliffe, H.E.6
Black, M.A.7
Donato, A.L.8
Arterburn, J.B.9
Oprea, T.I.10
-
45
-
-
77954244922
-
A critical review of fundamental controversies in the field of GPR30 research
-
Langer G, Bader B, Meoli L, Isensee J, Delbeck M, Noppinger PR, Otto C. A critical review of fundamental controversies in the field of GPR30 research. Steroids 2010, 75:603-610.
-
(2010)
Steroids
, vol.75
, pp. 603-610
-
-
Langer, G.1
Bader, B.2
Meoli, L.3
Isensee, J.4
Delbeck, M.5
Noppinger, P.R.6
Otto, C.7
-
46
-
-
84863983261
-
Position paper: The membrane estrogen receptor GPER/GPR30: Clues and questions
-
Barton M. Position paper: The membrane estrogen receptor GPER/GPR30: Clues and questions. Steroids 2012, 77:935-942.
-
(2012)
Steroids
, vol.77
, pp. 935-942
-
-
Barton, M.1
-
47
-
-
0031282001
-
Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer
-
Carmeci C, Thompson DA, Ring HZ, Francke U, Weigel RJ. Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics 1997, 45:607-617.
-
(1997)
Genomics
, vol.45
, pp. 607-617
-
-
Carmeci, C.1
Thompson, D.A.2
Ring, H.Z.3
Francke, U.4
Weigel, R.J.5
-
48
-
-
0031584830
-
Cloning of a Novel Member of the G Protein-Coupled Receptor Family Related to Peptide Receptors
-
Feng Y, Gregor P. Cloning of a Novel Member of the G Protein-Coupled Receptor Family Related to Peptide Receptors. Biochem Biophys Res Commun 1997, 231:651-654.
-
(1997)
Biochem Biophys Res Commun
, vol.231
, pp. 651-654
-
-
Feng, Y.1
Gregor, P.2
-
49
-
-
10844284696
-
Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins
-
Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, Pollack J, Peyton M, Zou Y, Kurie JM, Dimaio JM, et al. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 2004, 64:9027-9034.
-
(2004)
Cancer Res
, vol.64
, pp. 9027-9034
-
-
Ramirez, R.D.1
Sheridan, S.2
Girard, L.3
Sato, M.4
Kim, Y.5
Pollack, J.6
Peyton, M.7
Zou, Y.8
Kurie, J.M.9
Dimaio, J.M.10
-
50
-
-
0030779805
-
Establishment of Human Peripheral Lung Epithelial Cell Lines (HPL1) Retaining Differentiated Characteristics and Responsiveness to Epidermal Growth Factor, Hepatocyte Growth Factor, and Transforming Growth Factor β1
-
Masuda A, Kondo M, Saito T, Yatabe Y, Kobayashi T, Okamoto M, Suyama M, Takahashi T, Takahashi T. Establishment of Human Peripheral Lung Epithelial Cell Lines (HPL1) Retaining Differentiated Characteristics and Responsiveness to Epidermal Growth Factor, Hepatocyte Growth Factor, and Transforming Growth Factor β1. Cancer Res 1997, 57:4898-4904.
-
(1997)
Cancer Res
, vol.57
, pp. 4898-4904
-
-
Masuda, A.1
Kondo, M.2
Saito, T.3
Yatabe, Y.4
Kobayashi, T.5
Okamoto, M.6
Suyama, M.7
Takahashi, T.8
Takahashi, T.9
-
51
-
-
77953357626
-
Chronic exposure to estrogen and the tobacco carcinogen NNK cooperatively modulates nicotinic receptors in small airway epithelial cells
-
Al-Wadei HAN, Al-Wadei MH, Masi T, Schuller HM. Chronic exposure to estrogen and the tobacco carcinogen NNK cooperatively modulates nicotinic receptors in small airway epithelial cells. Lung Cancer 2010, 69:33-39.
-
(2010)
Lung Cancer
, vol.69
, pp. 33-39
-
-
Al-Wadei, H.A.N.1
Al-Wadei, M.H.2
Masi, T.3
Schuller, H.M.4
-
52
-
-
53349145473
-
Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma
-
Schuller HM, Al-Wadei HAN, Majidi M. Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma. Carcinogenesis 2008, 29:1979-1985.
-
(2008)
Carcinogenesis
, vol.29
, pp. 1979-1985
-
-
Schuller, H.M.1
Al-Wadei, H.A.N.2
Majidi, M.3
-
53
-
-
79956308108
-
G-1-Activated Membrane Estrogen Receptors Mediate Increased Contractility of the Human Myometrium
-
Maiti K, Paul JW, Read M, Chan EC, Riley SC, Nahar P, Smith R. G-1-Activated Membrane Estrogen Receptors Mediate Increased Contractility of the Human Myometrium. Endocrinology 2011, 152:2448-2455.
-
(2011)
Endocrinology
, vol.152
, pp. 2448-2455
-
-
Maiti, K.1
Paul, J.W.2
Read, M.3
Chan, E.C.4
Riley, S.C.5
Nahar, P.6
Smith, R.7
-
54
-
-
34548757535
-
The role of GPCR dimerisation/oligomerisation in receptor signalling
-
Milligan G, Canals M, Pediani JD, Ellis J, Lopez-Gimenez JF. The role of GPCR dimerisation/oligomerisation in receptor signalling. Ernst Schering Found Symp Proc 2006, 2006:145-161.
-
(2006)
Ernst Schering Found Symp Proc
, vol.2006
, pp. 145-161
-
-
Milligan, G.1
Canals, M.2
Pediani, J.D.3
Ellis, J.4
Lopez-Gimenez, J.F.5
-
55
-
-
0035726693
-
G-protein-coupled receptor dimerization: modulation of receptor function
-
Rios CD, Jordan BA, Gomes I, Devi LA. G-protein-coupled receptor dimerization: modulation of receptor function. Pharmacology & Therapeutics 2001, 92:71-87.
-
(2001)
Pharmacology & Therapeutics
, vol.92
, pp. 71-87
-
-
Rios, C.D.1
Jordan, B.A.2
Gomes, I.3
Devi, L.A.4
-
56
-
-
79951987933
-
G Protein-Coupled Estrogen Receptor 1/G Protein-Coupled Receptor 30 Localizes in the Plasma Membrane and Traffics Intracellularly on Cytokeratin Intermediate Filaments
-
Sandén C, Broselid S, Cornmark L, Andersson K, Daszkiewicz-Nilsson J, Mårtensson UEA, Olde B, Leeb-Lundberg LMF. G Protein-Coupled Estrogen Receptor 1/G Protein-Coupled Receptor 30 Localizes in the Plasma Membrane and Traffics Intracellularly on Cytokeratin Intermediate Filaments. Mol Pharmacol 2011, 79:400-410.
-
(2011)
Mol Pharmacol
, vol.79
, pp. 400-410
-
-
Sandén, C.1
Broselid, S.2
Cornmark, L.3
Andersson, K.4
Daszkiewicz-Nilsson, J.5
Mårtensson, U.E.A.6
Olde, B.7
Leeb-Lundberg, L.M.F.8
-
57
-
-
72449174718
-
GPR30 gene polymorphisms are associated with progesterone receptor status and histopathological characteristics of breast cancer patients
-
Giess M, Lattrich C, Springwald A, Goerse R, Ortmann O, Treeck O. GPR30 gene polymorphisms are associated with progesterone receptor status and histopathological characteristics of breast cancer patients. The Journal of steroid biochemistry and molecular biology 2010, 118:7-12.
-
(2010)
The Journal of steroid biochemistry and molecular biology
, vol.118
, pp. 7-12
-
-
Giess, M.1
Lattrich, C.2
Springwald, A.3
Goerse, R.4
Ortmann, O.5
Treeck, O.6
-
59
-
-
66049157034
-
The correlation between GPR30 and clinicopathologic variables in breast carcinomas
-
Tu G, Hu D, Yang G, Yu T. The correlation between GPR30 and clinicopathologic variables in breast carcinomas. Technol Cancer Res Treat 2009, 8:231-234.
-
(2009)
Technol Cancer Res Treat
, vol.8
, pp. 231-234
-
-
Tu, G.1
Hu, D.2
Yang, G.3
Yu, T.4
-
60
-
-
33947697810
-
GPR30: a novel indicator of poor survival for endometrial carcinoma
-
discussion 386 e389-311
-
Smith HO, Leslie KK, Singh M, Qualls CR, Revankar CM, Joste NE, Prossnitz ER. GPR30: a novel indicator of poor survival for endometrial carcinoma. Am J Obstet Gynecol 2007, 196(386):e381-e389. discussion 386 e389-311.
-
(2007)
Am J Obstet Gynecol
, vol.196
, Issue.386
-
-
Smith, H.O.1
Leslie, K.K.2
Singh, M.3
Qualls, C.R.4
Revankar, C.M.5
Joste, N.E.6
Prossnitz, E.R.7
-
61
-
-
33344461590
-
The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells
-
Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Ando S, Maggiolini M. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol Endocrinol 2006, 20:631-646.
-
(2006)
Mol Endocrinol
, vol.20
, pp. 631-646
-
-
Vivacqua, A.1
Bonofiglio, D.2
Recchia, A.G.3
Musti, A.M.4
Picard, D.5
Ando, S.6
Maggiolini, M.7
-
62
-
-
67749119671
-
GPR30 predicts poor survival for ovarian cancer
-
Smith HO, Arias-Pulido H, Kuo DY, Howard T, Qualls CR, Lee SJ, Verschraegen CF, Hathaway HJ, Joste NE, Prossnitz ER. GPR30 predicts poor survival for ovarian cancer. Gynecol Oncol 2009, 114:465-471.
-
(2009)
Gynecol Oncol
, vol.114
, pp. 465-471
-
-
Smith, H.O.1
Arias-Pulido, H.2
Kuo, D.Y.3
Howard, T.4
Qualls, C.R.5
Lee, S.J.6
Verschraegen, C.F.7
Hathaway, H.J.8
Joste, N.E.9
Prossnitz, E.R.10
-
63
-
-
33748923143
-
17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30
-
Vivacqua A, Bonofiglio D, Albanito L, Madeo A, Rago V, Carpino A, Musti AM, Picard D, Ando S, Maggiolini M. 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30. Mol Pharmacol 2006, 70:1414-1423.
-
(2006)
Mol Pharmacol
, vol.70
, pp. 1414-1423
-
-
Vivacqua, A.1
Bonofiglio, D.2
Albanito, L.3
Madeo, A.4
Rago, V.5
Carpino, A.6
Musti, A.M.7
Picard, D.8
Ando, S.9
Maggiolini, M.10
-
64
-
-
80054739275
-
G-protein Coupled Estrogen Receptor 1 Expression in Primary Breast Cancers and Its Correlation with Clinicopathological Variables
-
Luo HJ, Luo P, Yang GL, Peng QL, Liu MR, Tu G. G-protein Coupled Estrogen Receptor 1 Expression in Primary Breast Cancers and Its Correlation with Clinicopathological Variables. J Breast Cancer 2011, 14:185-190.
-
(2011)
J Breast Cancer
, vol.14
, pp. 185-190
-
-
Luo, H.J.1
Luo, P.2
Yang, G.L.3
Peng, Q.L.4
Liu, M.R.5
Tu, G.6
-
65
-
-
77955774697
-
GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer
-
Arias-Pulido H, Royce M, Gong Y, Joste N, Lomo L, Lee SJ, Chaher N, Verschraegen C, Lara J, Prossnitz ER, Cristofanilli M. GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer. Breast Cancer Res Treat 2010, 123:51-58.
-
(2010)
Breast Cancer Res Treat
, vol.123
, pp. 51-58
-
-
Arias-Pulido, H.1
Royce, M.2
Gong, Y.3
Joste, N.4
Lomo, L.5
Lee, S.J.6
Chaher, N.7
Verschraegen, C.8
Lara, J.9
Prossnitz, E.R.10
Cristofanilli, M.11
-
66
-
-
84860771546
-
Loss of GPER identifies new targets for therapy among a subgroup of ERalpha-positive endometrial cancer patients with poor outcome
-
Krakstad C, Trovik J, Wik E, Engelsen IB, Werner HM, Birkeland E, Raeder MB, Oyan AM, Stefansson IM, Kalland KH, et al. Loss of GPER identifies new targets for therapy among a subgroup of ERalpha-positive endometrial cancer patients with poor outcome. Br J Cancer 2012, 106:1682-1688.
-
(2012)
Br J Cancer
, vol.106
, pp. 1682-1688
-
-
Krakstad, C.1
Trovik, J.2
Wik, E.3
Engelsen, I.B.4
Werner, H.M.5
Birkeland, E.6
Raeder, M.B.7
Oyan, A.M.8
Stefansson, I.M.9
Kalland, K.H.10
-
67
-
-
79953168739
-
GPR30 Activation Opposes Estrogen-Dependent Uterine Growth via Inhibition of Stromal ERK1/2 and Estrogen Receptor Alpha (ERα) Phosphorylation Signals
-
Gao F, Ma X, Ostmann AB, Das SK. GPR30 Activation Opposes Estrogen-Dependent Uterine Growth via Inhibition of Stromal ERK1/2 and Estrogen Receptor Alpha (ERα) Phosphorylation Signals. Endocrinology 2011, 152:1434-1447.
-
(2011)
Endocrinology
, vol.152
, pp. 1434-1447
-
-
Gao, F.1
Ma, X.2
Ostmann, A.B.3
Das, S.K.4
-
68
-
-
0037169815
-
Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue
-
Fasco MJ, Hurteau GJ, Spivack SD. Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Mol Cell Endocrinol 2002, 188:125-140.
-
(2002)
Mol Cell Endocrinol
, vol.188
, pp. 125-140
-
-
Fasco, M.J.1
Hurteau, G.J.2
Spivack, S.D.3
-
71
-
-
53249107839
-
G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol
-
Otto C, Rohde-Schulz B, Schwarz G, Fuchs I, Klewer M, Brittain D, Langer G, Bader B, Prelle K, Nubbemeyer R, Fritzemeier KH. G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol. Endocrinology 2008, 149:4846-4856.
-
(2008)
Endocrinology
, vol.149
, pp. 4846-4856
-
-
Otto, C.1
Rohde-Schulz, B.2
Schwarz, G.3
Fuchs, I.4
Klewer, M.5
Brittain, D.6
Langer, G.7
Bader, B.8
Prelle, K.9
Nubbemeyer, R.10
Fritzemeier, K.H.11
-
72
-
-
77950407928
-
Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling
-
Kang L, Zhang X, Xie Y, Tu Y, Wang D, Liu Z, Wang ZY. Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol Endocrinol 2010, 24:709-721.
-
(2010)
Mol Endocrinol
, vol.24
, pp. 709-721
-
-
Kang, L.1
Zhang, X.2
Xie, Y.3
Tu, Y.4
Wang, D.5
Liu, Z.6
Wang, Z.Y.7
-
73
-
-
58149512521
-
GPR30 does not mediate estrogenic responses in reproductive organs in mice
-
Otto C, Fuchs I, Kauselmann G, Kern H, Zevnik B, Andreasen P, Schwarz G, Altmann H, Klewer M, Schoor M, et al. GPR30 does not mediate estrogenic responses in reproductive organs in mice. Biol Reprod 2009, 80:34-41.
-
(2009)
Biol Reprod
, vol.80
, pp. 34-41
-
-
Otto, C.1
Fuchs, I.2
Kauselmann, G.3
Kern, H.4
Zevnik, B.5
Andreasen, P.6
Schwarz, G.7
Altmann, H.8
Klewer, M.9
Schoor, M.10
-
74
-
-
0036893337
-
Progestin and G protein-coupled receptor 30 inhibit mitogen-activated protein kinase activity in MCF-7 breast cancer cells
-
Ahola TM, Alkio N, Manninen T, Ylikomi T. Progestin and G protein-coupled receptor 30 inhibit mitogen-activated protein kinase activity in MCF-7 breast cancer cells. Endocrinology 2002, 143:4620-4626.
-
(2002)
Endocrinology
, vol.143
, pp. 4620-4626
-
-
Ahola, T.M.1
Alkio, N.2
Manninen, T.3
Ylikomi, T.4
-
75
-
-
0036721112
-
G protein-coupled receptor 30 is critical for a progestin-induced growth inhibition in MCF-7 breast cancer cells
-
Ahola TM, Manninen T, Alkio N, Ylikomi T. G protein-coupled receptor 30 is critical for a progestin-induced growth inhibition in MCF-7 breast cancer cells. Endocrinology 2002, 143:3376-3384.
-
(2002)
Endocrinology
, vol.143
, pp. 3376-3384
-
-
Ahola, T.M.1
Manninen, T.2
Alkio, N.3
Ylikomi, T.4
-
76
-
-
0036098797
-
Progestin upregulates G-protein-coupled receptor 30 in breast cancer cells
-
Ahola TM, Purmonen S, Pennanen P, Zhuang YH, Tuohimaa P, Ylikomi T. Progestin upregulates G-protein-coupled receptor 30 in breast cancer cells. Eur J Biochem 2002, 269:2485-2490.
-
(2002)
Eur J Biochem
, vol.269
, pp. 2485-2490
-
-
Ahola, T.M.1
Purmonen, S.2
Pennanen, P.3
Zhuang, Y.H.4
Tuohimaa, P.5
Ylikomi, T.6
-
77
-
-
33847755409
-
G Protein-Coupled Receptor 30 (GPR30) Mediates Gene Expression Changes and Growth Response to 17{beta}-Estradiol and Selective GPR30 Ligand G-1 in Ovarian Cancer Cells
-
Albanito L, Madeo A, Lappano R, Vivacqua A, Rago V, Carpino A, Oprea TI, Prossnitz ER, Musti AM, Ando S, Maggiolini M. G Protein-Coupled Receptor 30 (GPR30) Mediates Gene Expression Changes and Growth Response to 17{beta}-Estradiol and Selective GPR30 Ligand G-1 in Ovarian Cancer Cells. Cancer Res 2007, 67:1859-1866.
-
(2007)
Cancer Res
, vol.67
, pp. 1859-1866
-
-
Albanito, L.1
Madeo, A.2
Lappano, R.3
Vivacqua, A.4
Rago, V.5
Carpino, A.6
Oprea, T.I.7
Prossnitz, E.R.8
Musti, A.M.9
Ando, S.10
Maggiolini, M.11
-
78
-
-
12344307170
-
Identity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer Cells
-
Thomas P, Pang Y, Filardo EJ, Dong J. Identity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer Cells. Endocrinology 2005, 146:624-632.
-
(2005)
Endocrinology
, vol.146
, pp. 624-632
-
-
Thomas, P.1
Pang, Y.2
Filardo, E.J.3
Dong, J.4
-
79
-
-
79955049817
-
Influence of polymorphisms on EGFR targeted therapy in non-small-cell lung cancer
-
Giovannetti E, Erdem L, Olcay E, Leon LG, Peters GJ. Influence of polymorphisms on EGFR targeted therapy in non-small-cell lung cancer. Front Biosci 2011, 16:116-130.
-
(2011)
Front Biosci
, vol.16
, pp. 116-130
-
-
Giovannetti, E.1
Erdem, L.2
Olcay, E.3
Leon, L.G.4
Peters, G.J.5
-
80
-
-
79957492069
-
American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non-Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy
-
Keedy VL, Temin S, Somerfield MR, Beasley MB, Johnson DH, McShane LM, Milton DT, Strawn JR, Wakelee HA, Giaccone G. American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non-Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy. J Clin Oncol 2011,
-
(2011)
J Clin Oncol
-
-
Keedy, V.L.1
Temin, S.2
Somerfield, M.R.3
Beasley, M.B.4
Johnson, D.H.5
McShane, L.M.6
Milton, D.T.7
Strawn, J.R.8
Wakelee, H.A.9
Giaccone, G.10
-
81
-
-
84863984601
-
Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy
-
Girgert R, Emons G, Grundker C. Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy. Breast Cancer Res Treat 2012, 134:199-205.
-
(2012)
Breast Cancer Res Treat
, vol.134
, pp. 199-205
-
-
Girgert, R.1
Emons, G.2
Grundker, C.3
|